Prophylaxis against covid-19: living systematic review and network meta-analysis
Updates This is the second version (first update) of the living systematic review, replacing
the previous version (available as a data supplement). When citing this paper please …
the previous version (available as a data supplement). When citing this paper please …
A living WHO guideline on drugs to prevent covid-19
Clinical question What is the role of drugs in preventing covid-19? Why does this matter?
There is widespread interest in whether drug interventions can be used for the prevention of …
There is widespread interest in whether drug interventions can be used for the prevention of …
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
G Zhou, S Verweij, MJ Bijlsma… - BMJ open …, 2023 - bmjopenrespres.bmj.com
Objective Current evidence on the effectiveness of SARS-CoV-2 prophylaxis is inconclusive.
We aimed to systematically evaluate published studies on repurposed drugs for the …
We aimed to systematically evaluate published studies on repurposed drugs for the …
Care for adults with COVID‐19: living guidelines from the National COVID‐19 Clinical Evidence Taskforce
H White, SJ McDonald, B Barber… - Medical Journal of …, 2022 - Wiley Online Library
Abstract Introduction The Australian National COVID‐19 Clinical Evidence Taskforce was
established in March 2020 to maintain up‐to‐date recommendations for the treatment of …
established in March 2020 to maintain up‐to‐date recommendations for the treatment of …
[HTML][HTML] Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
X García-Albéniz, J Del Amo, R Polo… - European Journal of …, 2022 - Springer
Background Recruitment into randomized trials of hydroxychloroquine (HCQ) for prevention
of COVID-19 has been adversely affected by a widespread conviction that HCQ is not …
of COVID-19 has been adversely affected by a widespread conviction that HCQ is not …
新型冠状病毒感染脆弱人群的识别及防治展望
郑劲平， 薛武军， 巨春蓉， 马军， 曾小峰 - 中国全科医学, 2024 - chinagp.net
新型冠状病毒感染疫情对人类健康和全球经济造成重创. 健康相关脆弱人群的免疫功能减退,
导致疫苗的防护效果不足, 并且, 感染新型冠状病毒后重症和死亡风险更高, 而目前尚缺乏足够有 …
导致疫苗的防护效果不足, 并且, 感染新型冠状病毒后重症和死亡风险更高, 而目前尚缺乏足够有 …
Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials
H Hong, A Friedland, M Hu, KJ Anstrom, S Halabi… - BMJ open, 2023 - bmjopen.bmj.com
Objective We studied the safety and efficacy of hydroxychloroquine (HCQ) as pre-exposure
prophylaxis for COVID-19 in healthcare workers (HCWs), using a meta-analysis of …
prophylaxis for COVID-19 in healthcare workers (HCWs), using a meta-analysis of …
[HTML][HTML] Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker …
Objectives To determine whether hydroxychloroquine (HCQ) is safe and effective at
preventing COVID-19 infections among health care workers (HCWs). Methods In a 1: 1 …
preventing COVID-19 infections among health care workers (HCWs). Methods In a 1: 1 …
[HTML][HTML] Pre-exposure prophylaxis with various doses of hydroxychloroquine among healthcare personnel with high-risk exposure to COVID-19: a randomized …
Objective This trial aimed to evaluate the safety and efficacy of pre-exposure prophylaxis
(PrEP) with various hydroxychloroquine (HCQ) doses against a placebo among healthcare …
(PrEP) with various hydroxychloroquine (HCQ) doses against a placebo among healthcare …
[HTML][HTML] The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis and clinical assessment: an updated meta-analysis of randomized trials
X Han, W Shi, Y Yang - Journal of Thoracic Disease, 2024 - ncbi.nlm.nih.gov
Background Coronavirus disease 2019 (COVID-19), a disease that affected tens of millions
of people, upended the lives of countless individuals around the globe. The chloroquine …
of people, upended the lives of countless individuals around the globe. The chloroquine …